Výsledky vyhledávání - "Sabrina Sarno"

Akademický článek

Overview of Current Targeted Anti-Cancer Drugs for Therapy in Onco-Hematology

Autor: Stefania Crisci, Filomena Amitrano, Mariangela Saggese, Tommaso Muto, Sabrina Sarno, Sara Mele, Pasquale Vitale, Giuseppina Ronga, Massimiliano Berretta, Raffaele Di Francia

Publikováno v: Medicina, Vol 55, Iss 8, p 414 (2019)

The upgraded knowledge of tumor biology and microenviroment provides information on differences in neoplastic and normal cells. Thus, the need to target these differences led to the development of novel molecules (targeted therapy) active against the

Externí odkaz: https://doaj.org/article/22101b6baa6c4083a4d1f231fdd6151a

Zobrazit plný text záznamu

Morphological and pathological features of basal-like breast cancer

Autor: Sabrina Sarno, Francesca Collina, Monica Cantile, Annamaria Anniciello, Gerardo Botti, Margherita Cerrone, Maurizio Di Bonito

Publikováno v: Translational Cancer Research

Basal-like breast cancer (BLBC) is characterized by high grade, high mitotic indices, presence of central necrotic or fibrotic zones, and lymphocytic infiltrate. Patients presenting with BLBC have a poor prognosis and a short-term disease-free and ov

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f800323d98ce1d4b9573400bc3e7b137
http://europepmc.org/articles/PMC8797286

Zobrazit plný text záznamu

The ratio of grzb+ − foxp3+ over cd3+ t cells as a potential predictor of response to nivolumab in patients with metastatic melanoma

Autor: Margherita Cerrone, Sabrina Sarno, Annabella Di Mauro, Mariaelena Capone, Giosuè Scognamiglio, Anna Maria Anniciello, Paolo A. Ascierto, Francesco Sabbatino, Monica Cantile, Marco Palla, Antonio M. Grimaldi, Gabriele Madonna, Domenico Mallardo, Gerardo Botti, Maurizio Di Bonito

Publikováno v: Cancers
Volume 13
Issue 10
Cancers, Vol 13, Iss 2325, p 2325 (2021)

Simple Summary Despite the recent success of immunotherapy in the treatment of malignant melanoma, many patients still do not benefit from these treatments, due to their failure to activate an antitumor immune response them. There is therefore a need

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::40134a31853989d1b5cf673d01a69f95
http://hdl.handle.net/11386/4779258

Zobrazit plný text záznamu

Inhibiting Monocyte Recruitment to Prevent the Pro-Tumoral Activity of Tumor-Associated Macrophages in Chondrosarcoma

Autor: Rosa Azzaro, Gaetano Apice, Lucia Cannella, Diana Boraschi, Michele Gallo, Maria Vincenza Carriero, Sabrina Sarno, Maria Patrizia Stoppelli, Michele Minopoli, Domenica Rea, Gioconda Di Carluccio, Alfredo Budillon, Katia Scotlandi, Annarosaria De Chiara, Flavio Fazioli, Susan Costantini

Publikováno v: Cells
Cells 9 (2020). doi:10.3390/cells9041062
info:cnr-pdr/source/autori:Minopoli M.; Sarno S.; Di Carluccio G.; Azzaro R.; Costantini S.; Fazioli F.; Gallo M.; Apice G.; Cannella L.; Rea D.; Stoppelli M.P.; Boraschi D.; Budillon A.; Scotlandi K.; De Chiara A.; Carriero M.V./titolo:Inhibiting Monocyte Recruitment to Prevent the Pro-Tumoral Activity of Tumor-Associated Macrophages in Chondrosarcoma/doi:10.3390%2Fcells9041062/rivista:Cells/anno:2020/pagina_da:/pagina_a:/intervallo_pagine:/volume:9
Cells, Vol 9, Iss 1062, p 1062 (2020)
Volume 9
Issue 4

Chondrosarcomas (CHS) are malignant cartilaginous neoplasms with diverse morphological features, characterized by resistance to chemo- and radiation therapies. In this study, we investigated the role of tumor-associated macrophages (TAM)s in tumor ti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8cda788e78177beca77d51ac73a99d1b
http://europepmc.org/articles/PMC7226304

Zobrazit plný text záznamu

Plný text ve formátu HTML

Crosstalk between Macrophages and Myxoid Liposarcoma Cells Increases Spreading and Invasiveness of Tumor Cells

Publikováno v: Cancers
Volume 13
Issue 13
Cancers, Vol 13, Iss 3298, p 3298 (2021)

Simple Summary Myxoid liposarcoma (MLPS) is the second most common subtype of liposarcoma, occurs predominantly in the extremities, and tends either to recur locally and metastasize to unusual soft tissue locations. To date, the mechanisms of invasio

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6ad2dac0c4ceb8c7cbf6fd11e2947cc
https://doi.org/10.3390/cancers13133298

Zobrazit plný text záznamu

Plný text ve formátu HTML

Immunohistochemical detection of paralogous 13 HOX genes in phyllodes tumor of the breast as a useful diagnostic tool

Autor: Sabrina, Sarno, Margherita, Cerrone, Vincenzo, Gigantino, Giosuè, Scognamiglio, Monica, Cantile, Gerardo, Botti, Maurizio, Di Bonito

Publikováno v: Int J Clin Exp Pathol

Phyllodes tumor of the breast is a rare fibroepithelial lesion characterized by a propensity for local recurrence and distant metastasis. Its histologic classification, based on morphology, mitotic index and tumor margin, includes malignant, borderli

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b5b4a8b9eee27e3707d1eb175f66ee1f
https://pubmed.ncbi.nlm.nih.gov/33042341

Zobrazit plný text záznamu

Structure-function relationship of an Urokinase Receptor-derived peptide which inhibits the Formyl Peptide Receptor type 1 activity

Autor: Maria Vincenza Carriero, Andrea Polo, Vincenzo Ingangi, Sabrina Sarno, Concetta Ragone, Alfredo Budillon, Gennaro Ciliberto, Michele Minopoli, Antonello Pessi, Susan Costantini

Publikováno v: Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-14 (2019)

The interaction between the short 88Ser-Arg-Ser-Arg-Tyr92 sequence of the urokinase receptor (uPAR) and the formyl peptide receptor type 1 (FPR1) elicits cell migration. We generated the Ac-(D)-Tyr-(D)-Arg-Aib-(D)-Arg-NH2 (RI-3) peptide which inhibit

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f8608aba747852a4b4361b6b4112f46
https://pubmed.ncbi.nlm.nih.gov/31434916

Zobrazit plný text záznamu

Plný text ve formátu HTML

Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion

Autor: Stefano Greggi, Maria Vincenza Carriero, Concetta Ragone, Maria Letizia Motti, Gennaro Ciliberto, María Roca, Nunzia Simona Losito, Vincenzo Gigantino, G. Botti, Cono Scaffa, Sabrina Sarno, Giosuè Scognamiglio, Maria Patrizia Stoppelli, Michele Minopoli

Publikováno v: Journal of Experimental & Clinical Cancer Research, Vol 38, Iss 1, Pp 1-16 (2019)
Journal of experimental & clinical cancer research (Testo stamp.) 38 (2019): 459. doi:10.1186/s13046-019-1465-8
info:cnr-pdr/source/autori:Minopoli, Michele; Botti, Giovanni; Gigantino, Vincenzo; Ragone, Concetta; Sarno, Sabrina; Motti, Maria Letizia; Scognamiglio, Giosuè; Greggi, Stefano; Scaffa, Cono; Roca, Maria Serena; Stoppelli, Maria Patrizia; Ciliberto, Gennaro; Losito, Nunzia Simona; Carriero, Maria Vincenza/titolo:Targeting the Formyl Peptide Receptor type 1 to prevent the adhesion of ovarian cancer cells onto mesothelium and subsequent invasion/doi:10.1186%2Fs13046-019-1465-8/rivista:Journal of experimental & clinical cancer research (Testo stamp.)/anno:2019/pagina_da:459/pagina_a:/intervallo_pagine:459/volume:38
Journal of Experimental & Clinical Cancer Research : CR

BackgroundThe biological behavior of epithelial ovarian cancer (EOC) is unique since EOC cells metastasize early to the peritoneum. Thereby, new anti-target agents designed to block trans-coelomic dissemination of EOC cells may be useful as anti-meta

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::656cb680adc92a51f2919bb0977b2698
http://hdl.handle.net/11367/82587

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání